Article
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
2022-05-31
Abstract excerpt
<h4>Background: </h4> Heart failure (HF) is a global pandemic which affects about 26 million people. PFKM (Phosphofructokinase, Muscle), catalyzing the phosphorylation of fructose-6-phosphate, plays a very important role in cardiovascular diseases. However, the effect of PFKM in glycolysis and HF remains to be elucidated. <h4>Materials: </h4> and methods: H9c2 rat cardiomyocyte cells were used in this study. Cells...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5fd7dda8-b65e-5b71-9175-e3ac190d7f32
- DOI
- 10.21203/rs.3.rs-1664969/v1
